Literature DB >> 12118324

Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.

Ki-Hyuk Shin1, Kyung-Hee Park, Hyun Jon Hong, Jin-Man Kim, Ju-Eun Oh, Pill-Hoon Choung, Byung-Moo Min.   

Abstract

To determine the etiologic factors of human oral cancer, we examined the prevalence of microsatellite instability (MSI), the inactivation of mismatch repair (MMR) genes, p53 mutation, and human papillomavirus (HPV) infection (HPV-16, -18, and -33) in 86 Korean oral cancer specimens, including 76 squamous cell carcinomas and 10 salivary gland tumors. MSI was observed in 3 of the 76 squamous cell carcinomas (4%) and 2 of 10 salivary gland tumors (20%). As MSI is a hallmark of the inactivation of the MMR genes, the genetic status of hMSH2 and hMLH1, and hypermethylation of the hMLH1 promoter region were investigated in oral cancers displaying MSI. Inactivation of the hMLH1 gene by either mutation or hypermethylation was observed 4 of the 5 MSI oral cancers. Mutation of the p53 gene was found in 11 of 76 squamous cell carcinomas (14.5%) but not in the salivary gland tumors. PCR assay revealed the presence of HPV DNA in 11 of the 76 squamous cell carcinomas (14.5%) and 4 of the 10 salivary gland tumors (40%). Type 18 HPV DNA was predominant in 11 of the HPV-infected squamous cell carcinomas (72.7%) and 4 of the HPV-infected salivary gland tumors (50%). Two squamous cell carcinoma tissues were found both to be HPV-infected and to harbor the p53 mutation. Our results suggest: i) that MSI plays a role in the pathogenesis of Korean oral cancers, squamous cell carcinomas (4%) and salivary gland tumors (20%); ii) that genetic alteration or hypermethylation of the hMLH1 gene may be the principal inactivating mechanism in Korean oral cancer with MSI; and iii) that inactivation of the p53 gene by either mutation or HPV infection is frequent in Korean squamous cell carcinomas (26%) and salivary gland tumors (40%).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118324

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Analysis of P53 mutation and invasion front grading in oral squamous cell carcinomas.

Authors:  Sanbao Tang; Dongxuan Xu; Bin Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinoma.

Authors:  Iman Salahshourifar; Vui King Vincent-Chong; Hong-Yun Chang; Hooi Leng Ser; Anand Ramanathan; Thomas George Kallarakkal; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Narayanan Prepageran; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Rosnah Binti Zain
Journal:  Clin Oral Investig       Date:  2015-04-08       Impact factor: 3.573

3.  Prevalence of HPV in Oral Squamous Cell Carcinoma in South West India.

Authors:  Pooja Dalakoti; Balakrishnan Ramaswamy; Ajay M Bhandarkar; Dipak Ranjan Nayak; Sasidharanpillai Sabeena; Govindakarnavar Arunkumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-21

4.  Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology.

Authors:  Soung Min Kim; Ik Jae Kwon; Hoon Myoung; Jong Ho Lee; Suk Keun Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-09       Impact factor: 2.503

Review 5.  The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.

Authors:  Katinka Kansy; Oliver Thiele; Kolja Freier
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

6.  Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.

Authors:  Young-Tak Kim; Beatriz Serrano; Jae-Kwan Lee; Hyunju Lee; Shin-Wha Lee; Crystal Freeman; Jin-Kyoung Oh; Laia Alemany; Francesc-Xavier Bosch; Laia Bruni
Journal:  Papillomavirus Res       Date:  2018-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.